Table 1 Clinical and laboratory study population characteristics
From: gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya
| Â | Male | Female | Total |
|---|---|---|---|
Gender | 332 (56.9%) | 251 (43.1) | 583 |
Gram staina | 168 (67.7%) | 80 (32.3) | 248 |
Aptima Combo −2®b | 205 (77.9%) | 58 (22.1) | 263 |
GC isolates | 73 (86.9%) | 11 (13.1%) | 84 |
Symptoms | Positive | Negative | Â |
 Dysuria | 463 (79.4%) | 120 (20.6%) | 583 |
 Backache | 274 (47%) | 309 (53%) | 583 |
 Lower abdominal pain | 388 (66.6%) | 195 (33.4%) | 583 |
 Fever | 261 (44.8%) | 322 (55.2%) | 583 |
 Itchy genitalia | 342 (58.7%) | 241 (41.3%) | 583 |